Free Trial
OTCMKTS:PVCT

Provectus Biopharmaceuticals (PVCT) Stock Price, News & Analysis

Provectus Biopharmaceuticals logo
$0.08 +0.00 (+1.19%)
As of 09:43 AM Eastern

About Provectus Biopharmaceuticals Stock (OTCMKTS:PVCT)

Key Stats

Today's Range
$0.07
$0.08
50-Day Range
$0.07
$0.10
52-Week Range
$0.04
$0.15
Volume
9,200 shs
Average Volume
196,726 shs
Market Capitalization
$32.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PVCT Stock News Headlines

How a Kansas farm boy gained 1,285% in two days
A former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a meme stock. It was a pattern called “Crossfire” — a 3-step setup you can execute in a normal brokerage app. Master trader Jeff Clark is now revealing how it works in a free 30-minute video, available for a limited time.
Provectus announces $3M seed financing round for VisiRose
Provectus announces the launch of VisiRose
See More Headlines

PVCT Stock Analysis - Frequently Asked Questions

Provectus Biopharmaceuticals' stock was trading at $0.1201 at the start of the year. Since then, PVCT shares have decreased by 37.1% and is now trading at $0.0756.

Shares of PVCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provectus Biopharmaceuticals investors own include Vertex Energy (VTNR), Good Times Restaurants (GTIM), Merck & Co., Inc. (MRK), Oncolytics Biotech (ONC), American Superconductor (AMSC), Cannabis Science (CBIS) and (DARA) (DARA).

Company Calendar

Today
7/09/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PVCT
Previous Symbol
NYSEMKT:PVCT
CIK
315545
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.76 million
Net Margins
-815.81%
Pretax Margin
-823.71%

Debt

Sales & Book Value

Annual Sales
$620 thousand
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-7.56

Miscellaneous

Free Float
358,499,000
Market Cap
$31.77 million
Optionable
Not Optionable
Beta
0.75
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:PVCT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners